I have maintained the same opinion of your last statement. Perhaps the reason for the suspension of warrants. Trying to get proper valuation and price all those in.
In looking at how many folks are stricken with this, depending on what the final endpoint indicates in living beyond 12 months and the cost of the drug, could it be higher??
makes sense, thanks BSB, hope DavidW sees thru your view. If FDA believes in that much that we still will meet the old endpoints where PFS is the Primary, don't you think we deserve much more than 10B from Merck? Just asking. I remember our inhouse math doc Dr. Bala always maintained PFS and OS are directly related meaning one goes well the other goes well too. What a stress free ticker we got now; a slam dunk endpoints to meet that come from a barrage of data of a big fat tail.
BSB, how can they meet the endpoints in the UK and the EU and not in the US when they are the same endpoints? There’s only one SAP, so there can only be one set of endpoints.